Semaglutide
Semaglutide is a GLP-1 receptor agonist peptide widely recognized for its role in metabolic and weight management research. By mimicking the naturally occurring glucagon-like peptide-1 (GLP-1) hormone, semaglutide has been extensively studied for its effects on appetite regulation, glucose metabolism, insulin response, and overall metabolic function.
Manufactured to high purity standards, semaglutide is supplied as a lyophilized peptide intended for laboratory and scientific research applications. Its long-acting profile and well-characterized mechanism of action have made it a significant focus of research in obesity, type 2 diabetes, and related metabolic conditions.
Key Features
- High-purity lyophilized peptide
- Long-acting GLP-1 receptor agonist
- Extensively studied in metabolic and weight management research
- Supports investigations into appetite regulation and glucose control
- Produced under stringent quality standards
Disclaimer: For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.